Craig A Johnson La Jolla Pharmaceutical CO (LJPC) insider trading activity

LJPC Quotes by TradingView

Craig A Johnson is Director of LA JOLLA PHARMACEUTICAL CO. Currently has a direct ownership of 0 shares of LJPC, which is worth approximately $0. The most recent transaction as insider was on Aug 22, 2022, when has been sold 12,000 shares (Common Stock) at a price of $6.23 per share, resulting in proceeds of $74,760. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Craig A Johnson Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 22 2022
SELL
Sale (or disposition) back to the issuer
$74,760 $6.23 p/Share
12,000 Reduced 100.0%
0 Common Stock
Jul 08 2022
BUY
Exercise of conversion of derivative security
$47,160 $3.93 p/Share
12,000 Added 50.0%
12,000 Common Stock

Also insider at

ODTC
Odonate Therapeutics, Inc. Financial Services
Director
HRTX
HERON THERAPEUTICS, INC. Healthcare
Director
MRTX
Mirati Therapeutics, Inc. Healthcare
AUPH
Aurinia Pharmaceuticals Inc. Healthcare
Director
CAJ

Craig A Johnson

Director
Waltham, MA

Track Institutional and Insider Activities on LJPC

Follow LA JOLLA PHARMACEUTICAL CO and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LJPC shares.

Notify only if

Insider Trading

Get notified when an La Jolla Pharmaceutical CO insider buys or sells LJPC shares.

Notify only if

News

Receive news related to LA JOLLA PHARMACEUTICAL CO

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on LJPC